These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
173 related items for PubMed ID: 20434542
1. Evaluation of the cytotoxicity of beta-cyclodextrin derivatives: evidence for the role of cholesterol extraction. Kiss T, Fenyvesi F, Bácskay I, Váradi J, Fenyvesi E, Iványi R, Szente L, Tósaki A, Vecsernyés M. Eur J Pharm Sci; 2010 Jul 11; 40(4):376-80. PubMed ID: 20434542 [Abstract] [Full Text] [Related]
2. [Cytotoxic examinations of various cyclodextrin derivatives on Caco-2 cells]. Kiss T, Fenyvesi F, Kovácsné BI, Fehér P, Leposáné KR, Váradi J, Szente L, Fenyvesi E, Iványi R, Vecsernyés M. Acta Pharm Hung; 2007 Jul 11; 77(2):150-4. PubMed ID: 17933275 [Abstract] [Full Text] [Related]
3. Evaluation of cholesterol depletion as a marker of nephrotoxicity in vitro for novel β-cyclodextrin derivatives. Wang H, Xie X, Zhang F, Zhou Q, Tao Q, Zou Y, Chen C, Zhou C, Yu S. Food Chem Toxicol; 2011 Jun 11; 49(6):1387-93. PubMed ID: 21426923 [Abstract] [Full Text] [Related]
7. Cytotoxicity of different types of methylated beta-cyclodextrins and ionic derivatives. Kiss T, Fenyvesi F, Pasztor N, Feher P, Varadi J, Kocsan R, Szente L, Fenyvesi E, Szabo G, Vecsernyes M, Bacskay I. Pharmazie; 2007 Jul 11; 62(7):557-8. PubMed ID: 17718201 [Abstract] [Full Text] [Related]
8. Some pharmaceutical and inclusion properties of 2-hydroxybutyl-β-cyclodextrin derivative. Ishiguro T, Morishita E, Iohara D, Hirayama F, Wada K, Motoyama K, Arima H, Uekama K. Int J Pharm; 2011 Oct 31; 419(1-2):161-9. PubMed ID: 21839823 [Abstract] [Full Text] [Related]
11. Methyl-beta-cyclodextrins: the role of number and types of substituents in solubilizing power. Fenyvesi É, Szemán J, Csabai K, Malanga M, Szente L. J Pharm Sci; 2014 May 31; 103(5):1443-52. PubMed ID: 24590624 [Abstract] [Full Text] [Related]
13. Involvement of PI3K-Akt-Bad pathway in apoptosis induced by 2,6-di-O-methyl-beta-cyclodextrin, not 2,6-di-O-methyl-alpha-cyclodextrin, through cholesterol depletion from lipid rafts on plasma membranes in cells. Motoyama K, Kameyama K, Onodera R, Araki N, Hirayama F, Uekama K, Arima H. Eur J Pharm Sci; 2009 Oct 08; 38(3):249-61. PubMed ID: 19664706 [Abstract] [Full Text] [Related]
14. Evaluation of the Cytotoxicity of α-Cyclodextrin Derivatives on the Caco-2 Cell Line and Human Erythrocytes. Róka E, Ujhelyi Z, Deli M, Bocsik A, Fenyvesi É, Szente L, Fenyvesi F, Vecsernyés M, Váradi J, Fehér P, Gesztelyi R, Félix C, Perret F, Bácskay IK. Molecules; 2015 Nov 11; 20(11):20269-85. PubMed ID: 26569209 [Abstract] [Full Text] [Related]
15. Physicochemical and biological properties of 2-O-α-D-galactosyl-cyclomaltohexaose (α-cyclodexterin) and -cyclomaltoheptaose (β-cyclodextrin). Okada Y, Semma M, Ichikawa A. Carbohydr Res; 2011 Jun 01; 346(8):1018-22. PubMed ID: 21477794 [Abstract] [Full Text] [Related]
19. Short synthesis of skeleton-modified cyclodextrin derivatives with unique inclusion ability. Kikuzawa A, Kida T, Nakatsuji Y, Akashi M. J Org Chem; 2005 Feb 18; 70(4):1253-61. PubMed ID: 15704958 [Abstract] [Full Text] [Related]
20. Bupivacaine hydrochloride complexation with some alpha- and beta-cyclodextrins studied by potentiometry with membrane electrodes. Kopecký F, Vojteková M, Kaclík P, Demko M, Bieliková Z. J Pharm Pharmacol; 2004 May 18; 56(5):581-7. PubMed ID: 15142334 [Abstract] [Full Text] [Related] Page: [Next] [New Search]